Extensive acrochordons and pancreatic islet‐cell tumors in tuberous sclerosis associated with TSC2 mutations

Acrochordons are frequently encountered benign skin lesions that may occasionally represent underlying pathology. Pancreatic islet‐cell tumors are rare neoplasms and few cases have been described in patients with tuberous sclerosis complex (TSC). A 39‐year‐old man presenting in acute renal failure was referred to us for further diagnostic evaluation of coincidentally noted dysmorphic features. Physical examination revealed over 1,000 acrochordons in addition to findings meeting criteria for TSC. The diagnosis was confirmed by disclosure of mutation in the TSC2 gene. Further evaluation revealed pancreatic islet cell tumors. Acrochordons are a common skin lesion, but when presenting in an atypical manner or unusual number may be a sign of TSC and underlying occult pathology thereby warranting evaluation of TSC2. Additionally, mutations in TSC2 gene may be a risk factor for developing pancreatic islet‐cell tumors. © 2006 Wiley‐Liss, Inc.

[1]  J. McNiff,et al.  Multiple facial angiofibromas: a cutaneous manifestation of Birt-Hogg-Dubé syndrome. , 2005, Journal of the American Academy of Dermatology.

[2]  S. Asa,et al.  Pancreatic Endocrine Tumors: An Update , 2004, Advances in anatomic pathology.

[3]  R. Boldrini,et al.  Malignant Pancreatic Endocrine Tumor in a Child With Tuberous Sclerosis , 2003, The American journal of surgical pathology.

[4]  W. James,et al.  Birt-Hogg-Dubé syndrome: a review of the literature and the differential diagnosis of firm facial papules. , 2003, Journal of the American Academy of Dermatology.

[5]  S. Demir,et al.  Acrochordon and impaired carbohydrate metabolism , 2002, Acta Diabetologica.

[6]  M. Eledrisi,et al.  Insulinoma in a patient with tuberous sclerosis: is there an association? , 2002, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[7]  M. Maloney,et al.  Acrochordons as a presenting sign of nevoid basal cell carcinoma syndrome. , 2001, Journal of the American Academy of Dermatology.

[8]  B. Zbar,et al.  Birt-Hogg-Dubé syndrome: a novel marker of kidney neoplasia. , 1999, Archives of dermatology.

[9]  S. Verhoef,et al.  Malignant pancreatic tumour within the spectrum of tuberous sclerosis complex in childhood , 1999, European Journal of Pediatrics.

[10]  J. Osborne,et al.  End-stage renal failure in adults with the tuberous sclerosis complex. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[11]  H. Northrup,et al.  Tuberous Sclerosis Complex Consensus Conference: Revised Clinical Diagnostic Criteria , 1998, Journal of child neurology.

[12]  R. Snell,et al.  Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products. , 1998, Human molecular genetics.

[13]  P. Borgen,et al.  Cowden's disease. A case report with analyses at the molecular level , 1992, Cancer.

[14]  P. Beighton,et al.  Genetic heterogeneity in tuberous sclerosis: phenotypic correlations. , 1990, Journal of medical genetics.

[15]  P. Boudes,et al.  [Cowden's disease]. , 1988, Presse medicale.

[16]  J. Polak,et al.  Pancreatic endocrine tumors: Immunocytochemical analysis of 125 tumors , 1982 .